Show
Sort by
-
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast
-
PIK3CA in breast cancer : a Belgian practical testing guideline
-
- Journal Article
- A1
- open access
Safety and immunogenicity of LY3415244, a bispecific antibody against TIM-3 and PD-L1, in patients with advanced solid tumors
-
Selective oral MEK1/2 inhibitor pimasertib : a phase I trial in patients with advanced solid tumors
-
Selective oral MEK1/2 inhibitor pimasertib in metastatic melanoma : antitumor activity in a phase I, dose-escalation trial
-
- Journal Article
- A1
- open access
The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients
-
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer : a phase 1 dose-escalation and dose-expansion study
-
Celyad's novel CAR T-cell therapy for solid malignancies
-
- Journal Article
- A1
- open access
Study protocol for THINK : a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types
-
Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies